CClinicalTrials.gg
RecruitingNCT05250284Updated Jul 13, 2026

The Intersection of Oncology Care and Worker Well-Being

An observational study in Solid Tumor, sponsored by University of Colorado, Denver. Recruiting at 1 site in United States. Open to male participants aged 21 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-07-13.

Sponsored by University of Colorado, Denver · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
400
Ages
21 Years to 70 Years
Sex
Male
01

Study summary

The goals of this study will be a greater understanding of cancer patients' well-being experience through the care/treatment continuum. An important aspect of the study is an understanding of work- and treatment-related challenges experienced by low-income men, many of whom will be Latino. At the 12-month observation period, the investigators will learn whether these men work long-term and how work status relates to well-being.

Read the detailed description

Labor supply and well-being outcomes will be evaluated at 3 timepoints (baseline, start of treatment, 12 months). The likelihood of remaining employed will be estimated with linear probability models as is the convention in labor economics. The study team also estimate employment using analogous logistic models, reporting marginal effects. Weekly hours worked will be estimated using ordinary least squares regression. In addition to measuring raw hours, the team estimate change and percent change in hours worked from baseline. These models can be expanded to accommodate control variables for worksite and job characteristics as well as accommodations, satisfaction, and other covariates predictive employment and hours worked.

Well-being will be assessed as specified by the Worker Well-Being Questionnaire (WellBQ) Manual23 and Patient Reported Outcomes Measurement Information Systems (PROMIS) domains. For PROMIS, subjects respond to a 4-item questionnaire for each domain. Responses are summed and standardized to t-scores, with higher t-scores representing higher levels of the domain measured. For example, an individual with a PROMIS depression t-score of 50 is the average observed in the general U.S. population, while a t-score of 60 indicates one standard deviation above the average score in the general population and represents moderate depressive symptoms. Guided by previous health literature, the team consider a half standard deviation (5-point) increase from initial scores a meaningful improvement for all PROMIS domains. The literature also suggests that meaningful change ranges from 2 to 6 points. Secondary to Aim 1, the team will assess the correlation between PROMIS measures and WellBQ. The WellBQ is at an earlier stage of adoption, warranting side-by-side comparison with established instruments like PROMIS. The InCharge instrument will be evaluated as suggested by the developers.

02

Conditions studied

  • Solid Tumor

Keywords

  • Newly Diagnosed Primary Solid Tumor
  • Men
  • Employed
  • Chemotherapy
  • Oral Agent
  • Radiation Therapy
03

Who can participate

Ages eligible
21 Years to 70 Years
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

sample consists of employed men newly diagnosed with a first primary solid tumor. define employed as working 10+ hours per week at diagnosis with the intention to continue working or return to work. Patients must be aged 21 to 70 years and within 2 months of initiating infusion chemotherapy, oral agent, or radiation therapy.

Eligibility criteria

Inclusion Criteria:

  • Males
  • Ages 21 to 70
  • Newly diagnosed with a first primary solid tumor
  • colorectal, lung, and head and neck
  • Currently employed (defined as working 10+ hours per week) with the intention to continue working or return to work
  • Within 2 months of initiating infusion chemotherapy, oral agent, or radiation therapy
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
400 participants (estimated)
Patient registry
No

Interventions

  • BehavioralWellBQ

    National Institue for Occupational Safety and Health Worker Well-Being Questionnaire is comprised of 21 scales (multiple items assessing a single construct) and 31 single items that cover worker well-being. Domains include (i) work evaluation and experience, (ii) workplace policies and culture, (iii) workplace physical environment and safety climate, (iv) health status, and (v) home, community, and society.

  • BehavioralPROMIS

    Patient-Reported Outcomes Measurement Information System is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults and children.

05

What researchers measure

Primary outcomes

  1. Employment Hours Worked

    Employment and weekly hours worked will be assessed using questions from the Current Population Survey (CPS)

    Time frame: 2 years

  2. Worker Well-being

    Worker well-being will be measured by the NIOSH WellBQ

    Time frame: 2 years

  3. Psychosocial Outcomes of Employed Males with Cancer using the validated Stress Thermometer.

    Depression and anxiety will be measured using the well-validated Stress Thermometer, a single item tool using a 0 (no distress) to 10 (extreme distress) - point Likert scale resembling a thermometer.

    Time frame: 2 years

  4. Psychosocial Outcomes of Employed Males with Cancer using PROMIS domains

    Psychosocial outcomes will be measured using the validated PROMIS domains. Subjects respond to a 4-item questionnaire for each domain. Responses are summed and standardized to t-scores, with higher t-scores representing higher levels of the domain measured. For example, an individual with a PROMIS depression t-score of 50 is the average observed in the general U.S. population, while a t-score of 60 indicates one standard deviation above the average score in the general population and represents moderate depressive symptoms.

    Time frame: 2 years

  5. Financial Burden of Employed Males with Cancer

    A systematic review of methods for measuring financial burden following cancer treatment identified 6 subdomains that represent perceptions of and reactions to financial distress: (i) financial spending, (ii) use of passive financial resources, (iii) psychosocial responses, (iv) support seeking, (v) coping with care or (vi) coping with ones' lifestyle.64 We chose the InCharge Financial Well-being/Financial Distress Scale (8 items) that covers most domains and is widely used in cancer patients.

    Time frame: 2 yearas

06

Study locations

1 of 1 sites recruiting
  • University of Colorado Anschutz Medical Campus
    Aurora, Colorado 80045, United States
    • Carol Brown · Contact · carol.brown@cuanschutz.edu
    • Carol E Brown · Sub investigator
    • Lee S Newman · Sub investigator
    • Liliana Tenney · Sub investigator
    • Brian D Williams · Sub investigator
    Recruiting
07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT05250284
Lead sponsor
University of Colorado, Denver
Collaborators
National Institute for Occupational Safety and Health (NIOSH/CDC)
Responsible party
Sponsor
First posted
Feb 22, 2022
Start date
Apr 4, 2022
Primary completion
Aug 31, 2027 (estimated)
Completion
Aug 31, 2027 (estimated)
Last update
Jul 13, 2026

Study contacts

Carol Brown, PhD
Contact
carol.brown@cuanschutz.edu
562.587.9123
Cathy Bradley
principal investigator · University of Colorado, Denver

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion